| Ytd | 34.54% | |
| 1y | 87.91% |
| Open | 59.95 | Prev Close | 60.36 | Low | 59.61 | High | 60.88 | Mkt Cap | 5.83B |
| Vol | 1.20M | Avg Vol | 1.28M | EPS | -4.70 | P/E | N/A | Forward P/E | -12.05 |
| Beta | 0.63 | Short Ratio | 3.23 | Inst. Own | 111.10% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 05-07 | 50-d Avg | 54.96 | 200-d Avg | 47.25 | 1yr Est | 80.56 |
Biohaven (BHVN) shares fall as BofA downgrades the stock to Underperform, citing a risky profile ahe
JP Morgan analyst Tessa Romero maintains Xenon Pharmaceuticals (NASDAQ:XENE) with a Overweight an
JP Morgan analyst Tessa Romero maintains Xenon Pharmaceuticals (NASDAQ:XENE) with a Overweight an
RBC Capital analyst Brian Abrahams maintains Xenon Pharmaceuticals (NASDAQ:XENE) with a Outperfor
Needham analyst Serge Belanger maintains Xenon Pharmaceuticals (NASDAQ:XENE) with a Buy and lower
Azetukalner data show significant reductions in seizure frequency across weekly, monthly and multi-y
Five abstracts accepted including Late-breaking Science oral and poster presentations of Phase 3 X-T
Wedbush analyst Laura Chico maintains Xenon Pharmaceuticals (NASDAQ:XENE) with a Outperform and l
Analysts change outlook on top names: Truist cut KFY price target, Oppenheimer raised AZO target, B.
Wells Fargo analyst Benjamin Burnett maintains Xenon Pharmaceuticals (NASDAQ:XENE) with a Overwei
Wedbush analyst Laura Chico maintains Xenon Pharmaceuticals (NASDAQ:XENE) with a Outperform and r
Deutsche Bank analyst David Hoang maintains Xenon Pharmaceuticals (NASDAQ:XENE) with a Buy and ra
HC Wainwright & Co. analyst Douglas Tsao maintains Xenon Pharmaceuticals (NASDAQ:XENE) with a
Xenon Pharmaceuticals Inc. (NASDAQ:XENE), a neuroscience-focused biopharmaceutical company dedicated
US stocks fell, Nasdaq down 1%, Dow down 1.71%, S&P 500 down 1.43%. Energy shares down 0.1%, con
Needham analyst Serge Belanger maintains Xenon Pharmaceuticals (NASDAQ:XENE) with a Buy and raise
Baird analyst Brian Skorney maintains Xenon Pharmaceuticals (NASDAQ:XENE) with a Outperform and r
Biohaven shares rose in premarket trading after Xenon's Phase 3 epilepsy study showed strong sei
US stocks tumble as Dow falls 650 points. Relmada Therapeutics stock rises 40.8% on promising cancer
US stocks fall as Dow Jones drops over 1% on Monday, while NASDAQ and S&P 500 also decline. Korn
Xenon Pharmaceuticals shares surge after Phase 3 data show strong seizure reduction for azetukalner,
X-TOLE2 met primary endpoint in both dose groups, including -53.2% median percent change (MPC) from
Needham analyst Serge Belanger maintains Xenon Pharmaceuticals (NASDAQ:XENE) with a Buy and raise
Wells Fargo analyst Benjamin Burnett maintains Xenon Pharmaceuticals (NASDAQ:XENE) with a Overwei
Wolfe Research analyst Rudy Li initiates coverage on Xenon Pharmaceuticals (NASDAQ:XENE) with a O
Biohaven's Phase 2 study with BHV-7000 in MDD did not meet its primary endpoint of reducing depr
Wells Fargo analyst Benjamin Burnett maintains Xenon Pharmaceuticals (NASDAQ:XENE) with a Overwei
Monthly reductions in seizure frequency of 90.9% among participants treated for ≥48 months in the OL
Xenon Pharmaceuticals Inc. (Nasdaq: XENE), a neuroscience-focused biopharmaceutical company dedicate
JP Morgan analyst Tessa Romero maintains Xenon Pharmaceuticals (NASDAQ:XENE) with a Overweight an
RBC Capital analyst Brian Abrahams maintains Xenon Pharmaceuticals (NASDAQ:XENE) with a Outperfor
Wells Fargo analyst Benjamin Burnett maintains Xenon Pharmaceuticals (NASDAQ:XENE) with a Overwei
Needham analyst Serge Belanger reiterates Xenon Pharmaceuticals (NASDAQ:XENE) with a Buy and main
Xenon Pharmaceuticals (NASDAQ:XENE) reported quarterly losses of $(1.15) per share which met the ana
VANCOUVER, British Columbia and BOSTON, Oct. 16, 2025 (GLOBE NEWSWIRE) -- Xenon Pharmaceuticals Inc.
Chardan Capital analyst Rudy Li maintains Xenon Pharmaceuticals (NASDAQ:XENE) with a Buy and main
Companies Reporting Before The Bell • Frontline (NYSE:FRO) is expected to report quarterly earnings
Companies Reporting Before The Bell • Flex LNG (NYSE:FLNG) is estimated to report earnings for its
Companies Reporting Before The Bell • Sony Group (NYSE:SONY) is estimated to report quarterly earni
Companies Reporting Before The Bell • Kosmos Energy (NYSE:KOS) is expected to report quarterly earn